A major reason for poor survival rates is late diagnoses, by which time the cancer cells have spread to secondary sites. (sciencedaily.com)
Patients whose tumors had a gene - expression signature associated with poor survival lived for a period that was 23 percent shorter than patients whose tumors did not have such a signature. (genome.gov)
This is the first study to suggest that red blood cell transfusions from young donors and from female donors may be associated with poorer survival in recipients. (sciencedaily.com)